Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sarcoma 48Lymphoma 34Lymphoma, Large B-Cell, Diffuse 32Lymphoma, Non-Hodgkin 23Osteosarcoma 21Hodgkin Disease 17Testicular Neoplasms 16Burkitt Lymphoma 13Testicular Germ Cell Tumor 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Ovarian Neoplasms 12Teratoma 9Neuroectodermal Tumors, Primitive, Peripheral 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Follicular 9Neuroblastoma 8Lymphoma, Large-Cell, Anaplastic 8Central Nervous System Neoplasms 8Recurrence 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell 7Leukemia 7Endodermal Sinus Tumor 7Seminoma 6Rhabdomyosarcoma 6Lymphoma, B-Cell, Marginal Zone 6Breast Neoplasms 6Small Cell Lung Carcinoma 5Neoplasms, Germ Cell and Embryonal 5Neoplasms 5

Interventions

pembrolizumab 2Vorinostat 2Vincristine 2Prednisone 2Doxorubicin 2Cyclophosphamide 2Bortezomib 2prednylidene 1pirarubicin 1etoposide phosphate 1Salvia hispanica seed extract 1Methotrexate 1Ifosfamide 1Everolimus 1Etoposide 1Cholecalciferol 1Brentuximab Vedotin 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Subcutaneous panniculitis-like T-cell lymphoma × Ifosfamide × Clear all
NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Ruijin Hospital

Phase 4 Unknown
200 enrolled
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡